Enable low abundant TH17 pathway biomarker monitoring

01 Nov 2012
Share
Leveraging TH17 pathway biomarkers in immune mediated inflammatory diseases is highly challenging due to their low abundance. High-definition Erenna® technology’s powerful suite of TH17 pathway immunoassay kits, with LLoQ down to the sub pictogram levels, offers researchers unique and novel insights, enabling quicker and more confident decision making.



Request Info


Company website

Singulex